Altogether, it seems that IL-38 can serve as an immunotherapeutic seroimmunobiomarker for cases with obesity and as a prognostic marker for the determination of susceptibility to T2DM [168]. Here, IL1F10 is linked to obesity due to melanocortin 4 receptor deficiency.